A Nature Genetics analysis of GTEx tissues and seven phenotypes shows that annotation and quantification method choices ...

Rotow, MD, explains how RNA-based next-generation sequencing (NGS) fits into testing for newly diagnosed advanced nonsquamous non-small cell lung cancer (NSCLC) in a discussion moderated by Matthew A.

Tempus xR RNA sequencing assay receives EU IVDR Class C certification, supporting continued clinical and biopharma access in ...

xR detects gene rearrangements and specific splice variants in solid tumor tissue to support clinical management. A published study demonstrated that combining Tempus RNA and DNA testing increases ...

Researchers at the University of Basel have released RNAmel, an open-source R/Shiny platform that combines a clickable bulk ...

Precision-cut lung slices allow researchers to study living human lung tissue outside the body, preserving the different cell ...

When you start research using a Next-Generation Sequencer (NGS), one of the first problems you face is, "How many reads are ...

MassBio is partnering with the ElevateBio team on November 2 to host 2026 R&D Reimagined – Techbio Solutions, the second in a ...

Pacific Biosciences of California PACB recently announced a collaboration with TychoBio, an AI-driven drug discovery company, ...

A research team led by distinguished professor Giuseppe Pezzotti at the Biomedical Engineering Center, Kansai Medical University (Japan), has demonstrated that differences in the molecular structures ...

Tempus AI (TEM) said Monday its xR solid tumor profiling assay has received Class C certification under the European Union's In Vitro Diagnostic Regulation for cancer genomic profiling. The company ...

New RNA extraction techniques overcome barriers to help scientists better evaluate treatments for diseases such as pulmonary ...